Business · 16/10/2026
National Cancer Institute; Amended Notice of Meeting
The National Cancer Institute has issued an amended notice of meeting.
Business · 16/10/2026
The National Cancer Institute has issued an amended notice of meeting.
LATEST SIGNALS
6Business · 10/18/2026
AbbVie is set to present new and updated data on its expanding portfolio of treatments for various types of cancer, including lung, colorectal, ovarian, prostate, and gastric cancers, at the 2026 ESMO Congress, showcasing the potential of its next-generation antibody-drug conjugates (ADCs) to address diverse patient needs.
Read summary →Business · 10/18/2026
Lilly will present early-stage data from its investigational treatments for ovarian cancer and other cancers at the 2026 ESMO Congress, highlighting its oncology pipeline progress.
Read summary →Business · 10/18/2026
A new study published in Spain found that children who used antibiotics from a young age were more likely to develop irritable bowel syndrome (IBS) by age 24, with the risk increasing with the number of antibiotic prescriptions
Read summary →Business · 10/18/2026
A new study published in Spain found that children who used antibiotics from a young age were more likely to develop irritable bowel syndrome (IBS) by age 24, with the risk increasing with the number of antibiotic prescriptions
Read summary →Business · 10/18/2026
A recent study presented at the UEG Week 2026 conference in Barcelona, Spain, suggests that using antibiotics from a young age may increase the risk of developing SII (a condition) in early adulthood.
Read summary →Business · 10/18/2026
A new study presented at the UEG Week 2026 conference in Barcelona, Spain, suggests that taking antibiotics from childhood into early adulthood may be associated with a higher risk of Irritable Bowel Syndrome (IBS) in young adults.
Read summary →